Login / Signup

Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?

Alexandre Olivier GérardAudrey LaurainGuillaume FavreMilou-Daniel DriciVincent L M Esnault
Published in: Diabetes care (2022)
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • diabetic nephropathy
  • high glucose
  • peritoneal dialysis